Active Ingredients: Dolutegravir 50 mg, Emtricitabine 200 mg, Tenofovir Alafenamide 25 mg
Strength: Fixed-dose combination
Brand Equivalent: Biktarvy
Exported By: Unnati Pharmax
💊 Product Overview
Kocitaf is a potent fixed-dose combination tablet containing Dolutegravir, Emtricitabine, and Tenofovir Alafenamide, used for the treatment of HIV-1 infection. Manufactured under stringent quality standards, Kocitaf is an export-grade formulation therapeutically equivalent to Biktarvy, providing comprehensive antiretroviral therapy in a single tablet.
This combination works synergistically to inhibit HIV replication at multiple stages of the viral life cycle, helping to reduce viral load, maintain immune function, and prevent disease progression. Globally trusted for its efficacy, Kocitaf meets GMP standards and ensures consistent therapeutic outcomes.
⭐ Key Features
✅ Fixed-dose combination: Dolutegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
✅ Potent triple antiretroviral therapy in a single tablet
✅ Manufactured under strict GMP guidelines
✅ Export-quality formulation with proven clinical effectiveness
✅ Convenient once-daily oral tablet dosage
✅ Reduces viral replication and supports immune system function
✅ High-quality, internationally recognized formulation
🩺 Indications & Uses
Kocitaf is indicated for:
✅ Treatment of HIV-1 infection in adults and adolescents
✅ Patients requiring combination antiretroviral therapy for viral suppression
✅ Suitable for treatment-naïve and treatment-experienced HIV patients
⚙️ Mechanism of Action
Dolutegravir: Integrase strand transfer inhibitor (INSTI) that prevents viral DNA integration into host cells
Emtricitabine: Nucleoside reverse transcriptase inhibitor (NRTI) that blocks viral RNA conversion to DNA
Tenofovir Alafenamide: Nucleotide reverse transcriptase inhibitor (NtRTI) that inhibits viral DNA synthesis
This triple mechanism effectively suppresses HIV replication and maintains immune system health.
⚠️ Dosage & Administration
Administered orally once daily, with or without food
Standard dose: 1 tablet daily or as prescribed by a healthcare professional
Dosage may be adjusted based on patient condition and tolerance
